Low-dose atropine drops to slow childhood nearsightedness
Part of Eyes & vision clinical trials.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 6 to 12 years old.
- Your child has mild to moderate nearsightedness (prescription between -1.00 and -4.00).
- No previous use of special myopia treatments (like special contacts or other atropine drops) in the past few months.
- Your child is generally healthy with no serious eye conditions or other medical issues listed.
- You and your child can commit to the study appointments and treatments for its duration.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This trial studies using low-dose atropine eye drops to help slow worsening nearsightedness (myopia) in children. It may help kids whose myopia is actively getting worse, depending on how consistently the drops are used.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.